The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.
Formerly are you serious? They have been negotiating a partnership deal for xf73 for nearly 2 years and now they are saying they need to change the phase 3 trial as it’s not attractive enough to go into partnership. Along with the fact that they don’t have any form of income there will be huge dilution this year and next.
No further progress, lack of interest in xf-73 is extremely worrying. Misleading that funds will last until Q1 2025 as current funds at the start of this year will only be enough for 12 months operating costs. As I’ve said numerous times there will be a fund raise in August this year. Then looks like there will be further massive dilution next year to fund phase 3 internally. This has been a lifestyle business for Bill Love.
You look back at Sajy’s past posts and he mentions about rumours circulating with other stocks, clearly trying to ramp the stock for his own agenda.
He also mentions countless times where he has been on a call with the company and received emails regarding sensitive information. Now I know senior management are showing complete incompetence in their running of Destiny but they aren’t stupid enough to put themselves at risk of a custodial sentence for a random guy on a chat board!
One is better off ignoring such posters, particularly when the stock is rising as they suck you in through FOMO.
Sajy, have you been down the pub again?
I recollect you saying a number of rumours that you have been privy too and none of them have come to fruition, like the time you said of a takeover by GSK for Destiny. You have zero credibility
Hopefully you see this as a learning rather than blindly shooting peoples opinions down that differ from yours. Sajyboy and you are very similar, the only difference is he has gone away licking his wounds and realised what a mistake this has been. I wanted out and was hoping to sell on an uplift on the day of news which didn’t occur, glad I sold on the day though. You still thinking this will be £2? I won’t ask how you get to this figure as I didn’t have meaningful response the last time I asked.
Brooko19 the problem you have is that you don’t like someone who has a different opinion to yourself. When a comment is made which doesn’t fit your narrative you call them a troll or as I can remember you called me a clown when I questioned the company and its history, that was when the price was at 75p. I remember at the same time you were calling this at £2 based on imminent news back in December, now who’s looking the clown. I asked you what you based this £2 valuation on and didn’t receive a particularly constructive response. Even though when you posted this £2 target you received numerous likes. I rest my case.
Alamo, companies don’t make further announcements based on a reaction to an issued RNS. They may issue an RNS if there has been significant share price reaction to no RNS. This is what you call a fully functioning market which has reacted accordingly to the latest news.
With no upfront payment for M3 and lack of clarity on a good partnership deal, this is now gripped with the fear of a fund raise this year. I can see this going back to 30p
Kipper it makes every sense to go down this route if the deal is a poor deal. Let’s not forget xf-73 negotiations started back in Sep 2022, that’s way over the average time for a deal being agreed and if there were any good deals put forward destiny would have agreed to them. Destiny have already been burnt with the M3 deal, which hammered the share price, they aren’t that stupid to repeat the same mistake. Something isn’t right here.
The RNS that stated CT is looking at all options to maximise shareholder value is telling. I believe this is code for saying current offers for XF-73 aren’t beneficial for Destiny and the company will therefore fund phase 3 trials on their own. This would make sense with the change in broker, looking to fund phase 3 trials via bonds and share dilution. This will drift lower until there is further clarity.